ProQR Therapeutics
PRQR
PRQR
32 hedge funds and large institutions have $97.1M invested in ProQR Therapeutics in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-5
Holders Change %
-13.51%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$19.7M |
| 2 |
SFM
2
Sphera Funds Management
Tel Aviv,
Israel
|
$1.3M |
| 3 |
AGA
3
Altrinsic Global Advisors
Stamford,
Connecticut
|
$1.78M |
| 4 |
4
Millennium Management
New York
|
$7.59M |
| 5 |
5
Jennison Associates
New York
|
$8.7M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
26
Sterling Capital Management
Charlotte,
North Carolina
| $92K | -$2.6K | -300 | -3% |
|
27
Wells Fargo
San Francisco,
California
| $30K | +$8.29K | +955 | +38% |
|
28
UBS Group
Zurich,
Switzerland
| $8K | -$2.06K | -246 | -20% |
|
|
HHMI
29
Howard Hughes Medical Institute
Chevy Chase,
Maryland
| $7K | -$384 | -42 | -5% |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | – | – | – |
|
31
Creative Planning
Overland Park,
Kansas
| $3K | – | – | – |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| $1K | -$7.13K | -791 | -88% |
|
|
CCP
33
Clough Capital Partners
Boston,
Massachusetts
| – | -$3.15M | -216,200 | Closed |
|
|
DM
34
Deerfield Management
New York
| – | -$3.05M | -209,398 | Closed |
|
|
CCM
35
Century Capital Management
Boston,
Massachusetts
| – | -$1.89M | -129,408 | Closed |
|
36
Marshall Wace
London,
United Kingdom
| – | -$945K | -64,886 | Closed |
|
37
Morgan Stanley
New York
| – | -$488K | -33,516 | Closed |
|
38
Goldman Sachs
New York
| – | -$162K | -11,135 | Closed |
|
39
Walleye Trading
New York
| – | -$28K | -1,900 | Closed |
|